Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

DBP has signed an agreement with Apotek365 for the sale of Pileseptin and HalsEze

Double Bond Pharmaceuticals subsidiary Drugsson and the online pharmacy Apotek365 has signed an agreement to sell HalsEze and Pileseptin. "Another pharmacy shows interest in the products, and we are happy for the collaboration with Apotek365," commented Igor Lokot, CEO of Double Bond Pharma and Drugsson AB. More about Apotek365: www.apotek365.se More about HalsEze och Pileseptin: www.drugsson.com This information is information that Double Bond Pharmaceutical International AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for

The Qt Company and Toradex announce partnership to accelerate software development

Qt Group Plc   Press Release   20th August 2018The Qt Company, the provider of the leading device creation framework Qt, today announced a software development partnership with Toradex, the preferred computing solution provider focusing on low to medium volume projects in the embedded industry. With today’s technology environment, companies looking into developing embedded devices are concerned with keeping costs at a minimum while getting their product to market quickly and providing their end user with the best experience. Through this partnership, The Qt Company and Toradex have

Nitro Games Oyj: Interim report Jan – June 2018

The interim period January – June 2018 · Revenues (Jan-June) increased by 34 % to 1 051.66 KEUR ( 787.92 KEUR on corresponding period 2017). · EBITDA amounted to -2 152.87 KEUR (corresponding period 2017: -620.90 KEUR). · EBIT: Operating result before financial items amounted to – 2 466.06 KEUR (-980.79 KEUR). · Net profit: The net result for the period amounted to -2 476.09 KEUR (- 1 096.35 KEUR). · As of June 30, cash and cash equivalents amounted to 1 422.69 KEUR. · The company had 570.60 KEUR of short-term receivables as of June 30. April – June 2018 ·

Invitation to Starbreeze quarterly presentation at Twitch on 21 August at 10 am

STOCKHOLM, SWEDEN (20 August, 2018)   Welcome to Starbreeze IR Live Stream at Twitch on 21 August 2018. At 10 am CET, Starbreeze CEO Bo Andersson Klint and CFO Sebastian Ahlskog will host a live stream and present the interim report for the second quarter on Starbreeze Twitch channel: https://www.twitch.tv/starbreeze  Please submit your questions to us in advance by sending an email to ir@starbreeze.com. Mark your questions “IR live stream”. If you have a Twitch account, you can also ask your questions in the chat. The interim report Q2 2018 will be published the same day at 8:00

Skanska to build residential block in Gothenburg, Sweden, for about SEK 500 M

Skanska has signed an agreement with the City of Gothenburg to build a residential block with 249 apartments in Gothenburg, Sweden. The contract is worth about SEK 500 M, which will be included in the order bookings for Skanska Sweden in the third quarter of 2018.The project, which will be built around an old factory, will comprise of apartments as well as retail areas and a pre-school. Work is already under way and is scheduled to be completed summer of 2021. Skanska is one of the leading development and construction companies in the Nordics, with operations in building construction and

Tikomed to initiate ALS clinical trial for which the UK Medicines and Healthcare products Regulatory Agency has granted permission

Viken, August 20[th], 2018 — TIKOMED, a specialty pharmaceutical company focused on developing therapeutics for treating acute and degenerative neurological and ophthalmic diseases, has been granted permission by the UK Medicines and Healthcare products Regulatory Agency, for a phase II clinical trial of the company’s investigational drug ILB for patients with Amyotrophic Lateral Sclerosis (ALS), to be conducted at Birmingham University Hospital. Anders Svenson M.D., Chief Medical Officer of TIKOMED, commented, “We are very pleased that the UK Medicines and Healthcare products Regulatory

PONTUS SUNDIN JOINS BRUNSWICK REAL ESTATE

Stockholm, 20 August 2018 Brunswick Real Estate, which recently held the final close of its second senior debt fund in the Nordics, thereby reaching over SEK 8.5 billion (MEUR 830) under management, recruits Pontus Sundin from Helaba to its Debt team.Pontus Sundin, with an extensive real estate and credit background from Helaba, Nordea, GE Real Estate and Hypo Real Estate, will be joining Brunswick Real Estate in September. Brunswick Real Estate Capital, the credit arm of Brunswick Real Estate, is the leading Nordic capital provider focusing solely on Nordic real estate debt.

Nuuka has signed a new agreement with a big Swedish supermarket chain to install their technology in a further +50 buildings.

It was announced in January that ICA Real Estate would use Nuuka’s software in pilot-projects to monitor, analyze and improve the efficiency of a few of their assets https://www.icafastigheter.se/nyheter/digital-innovation/ .The ultimate goal of the co-operation was to evaluate how ICA Real Estate could maintain their properties even more efficiently and sustainable. ICA Real Estate wants to create the best shopping experience for their customers and at the same time provide a great workplace for their employees through digitalization. The trial period of Nuuka’s Connect and Create

Share buy-backs in Telia Company during week 33 2018

During the period August 13, 2018 – August 17, 2018, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2 300 000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 20, 2018. The share buy-back programme, which runs between April 23, 2018 and March 22, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (”MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the “Safe Harbour Regulation”).During the period August 13,

Leading Chinese rail transit company UniTTEC selects IFS Applications as its unified ERP platform

Comprehensive IFS solution to provide transparency across UniTTEC’s diverse operations and robust support for complex project management IFS , the global enterprise applications company, announces that UniTTEC Co., Ltd , China's leading supplier of integrated solutions for rail transit, energy saving, and environmental protection has decided to implement IFS Applications™ . The solution will be implemented and supported by Beijing GuoZhiYunDing Software (GuoZhiYunDing), a member of

Director/PDMR Shareholding

17 August 2018 Faroe Petroleum plc ("Faroe Petroleum" or the "Company") Notification of Directors' interests On 17 August 2018, Jonathan Robert Cooper, the Chief Financial Officer of the Company transferred a total of 16,354 ordinary shares of 10 pence each in the share capital of the Company ("Ordinary Shares") to his wife Sarah Natalie Cooper at a price of £1.399 per Ordinary Share. Mr Cooper has retained the balance of his shareholding in the Company of 638,471 Ordinary Shares. Notification and public disclosure of transactions by persons discharging managerial

Fiskars Corporation: Acquisition of Own Shares 17.08.2018

Fiskars Corporation NOTIFICATION   17.08.2018 at 18:30 EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 17.08.2018 Date 17.08.2018Exchange transaction BuyShare class FSKRSAmount 1500Average price/share 18.6027 EURHighest price/share 18.6800 EURLowest price/share 18.5400 EURTotal price 27,904.05 EUR The shares held by Fiskars Corporation on 17.08.2018: FSKRS  235,361 On behalf of Fiskars CorporationSkandinaviska Enskilda Banken AB (Publ)   Antti Salakka    Janne

EAB Group Plc: SHARE REPURCHASE 17.8.2018

EAB GROUP Plc                            ANNOUNCEMENT           17.8.2018 SHARE REPURCHASE 17.8.2018 In the Helsinki Stock Exchange Trade date 17.8.2018Bourse trade BUYShare EABGBAmount 296 sharesTotal cost 1 166,24 EURAverage price/ share 3,9400 EUR EAB Group Plc now holds a total of 16.464 sharesincluding the shares repurchased on 17.8.2018. On behalf of EAB Group Plc. Nordea Bank AB (publ), Finnish Branch Janne Sarvikivi         Ilari IsomäkiFurther information:EAB Group Plc

Hexagon Composites ASA: Mandatory notification of trade

On 17 August 2018, Flakk Gruppen AS purchased 31,415 shares in Hexagon Composites ASA at an average price of NOK 23.50 per share. Flakk Gruppen AS is a company controlled by Knut Flakk, Chairman of Hexagon Composites ASA. After the transaction Flakk Gruppen AS holds 31,415 shares. The total holding of Knut Flakk and his close associates, is 30,947,132 shares in Hexagon Composites ASA. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Orkla ASA: Trade subject to notification - treasury shares

Orkla ASA has on 17 August 2018 bought 270,000 Orkla shares through broker at an average price of NOK 70.5331 per share. Orkla's total holding of treasury shares after this transaction is 17,483,259 shares. Orkla ASAOslo, 17 August 2018Ref.:IR & Communications ManagerElise A. HeidenreichTel.: +47 951 41 147 This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

#18-1463 Recalculation of reference value for certain instruments with Tesla Motors Inc. as underlying security

The reference value for certain certificates with Tesla Motors Inc. as underlying has been recalculated in accordance with the instruments final terms. This applies to the following instruments: Symbol: BULL TSLA X10 V3 Symbol: BULL TSLA X10 V2 Symbol: BULL TSLA X10 V The instruments will be traded under observation for the duration of this trading day.For more information concerning the recalculation, please contact the issuer of the affected instrument. For further information concerning this NGM notice please contact: NGM market surveillance, +46 8 566 390 55,

DNB ASA – Share buy-back status after week 33

During week 33 2018, DNB ASA has purchased 535 000 own shares at an average price of NOK 166.02 per share. After this, DNB ASA owns a total of 8 537 000 own shares. The repurchase of shares is part of the share buy-back programme announced by DNB ASA on 6 June 2018. The buy-back programme comprises up to approximately 24.1 million shares, of which up to approximately 15.9 million shares may be repurchased in the open market. The rest will be redeemed from the state of Norway on a proportionate basis, subject to approval from DNB ASA's annual general meeting in 2019, so that its current

Etteplan Oyj - Managers' Transactions

ETTEPLAN OYJ, Stock Exchange Release, August 17, 2018 at 5.30 p.m. Etteplan Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Riku RiikonenPosition: Other senior manager(X) Legal personIssuer: Etteplan OyjLEI: 7437006I5533R06JU690Notification type: INITIAL NOTIFICATIONReference number: 7437006I5533R06JU690_20180817100739_3____________________________________________Transaction date: 2018-08-15Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009008650Nature of the

Eniro publishes prospectus

This press release may not be announced, published or distributed, in whole or in part, directly or indirectly, in the United States, Canada, Japan, Australia, Hong Kong, New Zealand, Singapore, South Africa or any other country where such publication or distribution would violate applicable laws or rules or would require additional documents to be prepared or registered or require any other actions to be taken, in addition to the requirements under Swedish law. This press release is not a prospectus. For further information, please refer to “Important information” in this press release.

MQs result for the fourth quarter lower than previous year

Sales during the quarter has not developed as expected. The unusual warm summer has resulted in reduced traffic, lower sales and higher price reductions. MQ Holding AB estimates that the operating profit for the fourth quarter 2017/2018 will be approximately SEK 2 million, compared to SEK 33 million for the fourth quarter 2016/2017. All figures are preliminary and will be determined in MQ Holdings financial report for the fourth quarter, June - August 2018. The financial report will be published as planned on October 4 at 07.15, followed by a telephone conference at 08.30 the same day.

Navamedic ASA: Invitation to presentation of second quarter 2018

Navamedic ASA invites you to a presentation of the second quarter 2018 figures. The presentation will take place at Felix Konferansesenter, Aker Brygge, Oslo, Friday 24 August. The presentation will start at 08.00 The presentation will be webcasted live on www.navamedic.com - investor relations-presentations-webcast at 08.00 CET.  Shortly after the presentation the webcast recording will be published on the same site. Representatives from the Company will be: CEO Tom Rönnlund CFO Toril Ås For further information, please contact: Toril Ås Chief Financial Officer Mobile: +47

#18-1462 Listing of Knock out warrants issued by BNP Paribas Issuance B.V.

As from August 20, 2018, 4 Knock out warrants issued by BNP Paribas Issuance B.V. will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Issuance B.V. Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from August 20, 2018 and forward or until time for knock out event Market Maker: BNP Paribas Arbitrage SNC Underlying: DAX 30 Index OMXS30 index Current values of strike and barrier can be found at: [ NGM Market Data Web -

Cyxone changes Certified Adviser to Mangold Fondkommission AB

Cyxone AB (publ) announced today that the company changes Certified Adviser.Cyxone has entered an agreement with Mangold Fondkommission AB regarding the service as Certified Adviser. Mangold Fondkommission AB will act as the Certified Adviser as of August 21, 2018. Until then, Erik Penser Bank will continue to act as Certified Adviser to the company. ContactCyxone AB (publ)Kjell G. Stenberg, CEOTel: +46 (0) 723 816 168Email: kjell.g.stenberg@cyxone.comAdelgatan 21221 22 MalmöSwedenwww.cyxone.com About CyxoneCyxone AB is a clinical stage biotech company with a

#18-1461 Listing of Turbo warrants issued by BNP Paribas Issuance B.V.

As from August 20, 2018, 8 Turbo warrants issued by BNP Paribas Issuance B.V. will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Issuance B.V. Type of security: Call and put Turbo warrants of European type Execution: Automatic cash settlement Term: As from August 20, 2018 to expiry date Market Maker: BNP Paribas Arbitrage SNC Underlying: DAX 30 Index OMXS30 index For more details see attached file. For further information concerning this NGM notice please

There are no items matching the current filter
There are no more items matching the current filter
Back to top